Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.

Detalles Bibliográficos
Autores principales: Lara Moscoloni, Luis Felipe, Santarelli, Maximiliano, Spagnuolo, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995483/
https://www.ncbi.nlm.nih.gov/pubmed/33796443
http://dx.doi.org/10.1016/j.eucr.2021.101629
Descripción
Sumario:Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.

Ejemplares similares